These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1689845)

  • 21. An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL.
    Dighiero G
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):283-8. PubMed ID: 3065729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CD5 B cell.
    Kipps TJ
    Adv Immunol; 1989; 47():117-85. PubMed ID: 2479233
    [No Abstract]   [Full Text] [Related]  

  • 23. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
    Defrance T; Vanbervliet B; Durand I; Banchereau J
    Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice.
    Novelli EM; Ramírez M; Leung W; Civin CI
    Stem Cells; 1999; 17(5):242-52. PubMed ID: 10527459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
    Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
    Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoreactivity and CD5+ B cells.
    Hayakawa K
    Curr Opin Immunol; 1989-1990 Apr; 2(4):582-7. PubMed ID: 2484157
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoimmunity in chronic lymphocytic leukemia: which B lymphocyte is the culprit?
    Lugassy G
    Isr Med Assoc J; 2006 Dec; 8(12):864. PubMed ID: 17214107
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoimmune diseases and monoclonal gammopathies.
    Youinou P; Le Corre R; Dueymes M
    Clin Exp Rheumatol; 1996; 14 Suppl 14():S55-8. PubMed ID: 8722201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
    Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
    Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CD5 positive b-lymphocytes in autoimmunity: possible role in Graves' disease].
    Afeltra A; Russo S; Peri C; Paggi A
    Riv Eur Sci Med Farmacol; 1995; 17(5):167-74. PubMed ID: 8766784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of immature-B-cell phenotype, mouse-erythrocyte-rosette receptor expression, by mitogen treatment of normal peripheral B-cells.
    Ozgün S; Akoğlu T
    Br J Haematol; 1991 May; 78(1):139-40. PubMed ID: 2043475
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
    Deane M; Norton JD
    Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CD5+ B-cell.
    Dono M; Cerruti G; Zupo S
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2105-11. PubMed ID: 15313456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage?
    Hayakawa K; Hardy RR
    Annu Rev Immunol; 1988; 6():197-218. PubMed ID: 3289567
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases.
    Kipps TJ; Carson DA
    Blood; 1993 May; 81(10):2475-87. PubMed ID: 8490163
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression and ontogeny of CD2 on murine B cells.
    Sen J; Rosenberg N; Burakoff SJ
    J Immunol; 1990 Apr; 144(8):2925-30. PubMed ID: 1691222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The detection of minimal residual disease status in chronic lymphocytic leukemia.
    Marti GE
    Cytometry B Clin Cytom; 2011 Nov; 80(6):344-5. PubMed ID: 22002904
    [No Abstract]   [Full Text] [Related]  

  • 38. The development and repertoire of B-1 cells (CD5 B cells).
    Kantor AB
    Immunol Today; 1991 Nov; 12(11):389-91. PubMed ID: 1723875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
    Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
    Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.